Start for free
Start for free
Alexandria Venture Investments logo

Alexandria Venture Investments

North America, California, United States, Pasadena

Description

Alexandria Venture Investments is a venture capital firm that develops the work in real estate technology, and healthcare sectors.

Investor Profile

Alexandria Venture Investments has made 274 investments, with 32 in the past 12 months and 6% as lead.

Stage Focus

  • Series A (38%)
  • Series B (26%)
  • Series C (12%)
  • Seed (10%)
  • Series Unknown (5%)
  • Series D (2%)
  • Post Ipo Equity (2%)
  • Convertible Note (2%)
  • Series E (1%)

Country Focus

  • United States (95%)
  • Canada (2%)
  • France (2%)
  • Switzerland (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science
  • Pharmaceutical
  • Biopharma
  • Genetics
  • Oncology
  • Agriculture
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alexandria Venture Investments frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 24
Pfizer Venture Investments
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 19
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 22
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 31
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 29
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 20
Polaris Partners
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 22
Invus
Invus
North America, New York, United States, New York
Co-Investments: 17
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 48
Fidelity
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 20

Which angels does Alexandria Venture Investments often collaborate with?

MC
Michael Chambers
North America, North Dakota, United States, Fargo
Shared Deals: 1
Tim Disney
Shared Deals: 2
JM
John Mumm
North America, United States
Shared Deals: 1
BG
Bill Gates
North America, Washington, United States, Seattle
Shared Deals: 3
TA
Timothy A. Springer
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
MA
Milad Alucozai
North America, California, United States, San Francisco
Shared Deals: 1
CP
Chris Paul
North America, California, United States, San Francisco
Shared Deals: 1
GL
Gary Loveman
North America, Connecticut, United States, Hartford
Shared Deals: 1
FB
Franklin Berger
North America, New York, United States, New York
Shared Deals: 2
JB
John Ballantyne
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by Alexandria Venture Investments?

Remedy Plan Therapeutics

Gaithersburg, Maryland, United States

Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.

BiotechnologyHealth DiagnosticsMedicalTherapeutics
Series UnknownMay 13, 2025
Amount Raised: $18,000,000
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series AMay 8, 2025
Amount Raised: $65,000,000
Hoofprint Biome

Raleigh, North Carolina, United States

Hoofprint Biome is a biotechnology company that develops probiotics that improve the sustainability of ruminant livestock production.

Animal FeedBiotechnologyLife ScienceLivestock
Series AApr 29, 2025
Amount Raised: $15,000,000
Solu Therapeutics

Boston, Massachusetts, United States

Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.

BiotechnologyMedicalTherapeutics
Series AApr 9, 2025
Amount Raised: $41,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Latigo Biotherapeutics

Thousand Oaks, California, United States

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

BiotechnologyHealth CareMedicalTherapeutics
Series BMar 17, 2025
Amount Raised: $150,000,000
Avalo

Durham, North Carolina, United States

Avalo is a plant biotech company using AI and evolution to make a more sustainable and resilient food system.

AgricultureBiotechnologyMachine Learning
Series AMar 6, 2025
Amount Raised: $11,000,000
Eikon Therapeutics

Hayward, California, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

BiotechnologyHealth CareLife ScienceMedical
Series DFeb 26, 2025
Amount Raised: $350,700,000
Umoja Biopharma

Seattle, Washington, United States

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

BiopharmaBiotechnologyDeveloper Platform
Series CJan 14, 2025
Amount Raised: $100,000,000
nChroma Bio

Boston, Massachusetts, United States

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

BiotechnologyMedicalProduct Research
Series UnknownDec 11, 2024
Amount Raised: $75,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator